Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,839 INR | +1.26% | -1.27% | +2.37% |
May. 31 | Transcript : Apollo Hospitals Enterprise Limited, Q4 2024 Earnings Call, May 31, 2024 | |
May. 31 | Apollo Hospitals Enterprise Posts Gains in Fiscal Q4 Consolidated Net Profit | MT |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 89.05 times its estimated earnings per share for the ongoing year.
- The company's enterprise value to sales, at 4.55 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+2.37% | 10.06B | B+ | ||
-23.39% | 15.56B | B+ | ||
-2.70% | 11.65B | B | ||
+2.65% | 11.58B | B+ | ||
+29.48% | 8.7B | B | ||
-10.45% | 7.16B | A- | ||
+8.05% | 6.85B | B- | ||
-4.29% | 5.71B | D | ||
-3.96% | 4.3B | - | ||
+13.33% | 4.3B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- APOLLOHOSP Stock
- Ratings Apollo Hospitals Enterprise Limited